Global Blood Therapeutics
Based in CA
🤖
AI Overview
With $3.3M in lobbying spend across 20 quarterly filings, Global Blood Therapeutics is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2018 to 2022.
$3.3M
Total Spend
5
Years Active
1
Firms Hired
3
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $131K |
| 2019 | $575K |
| 2020 | $585K |
| 2021 | $780K |
| 2022 | $1.2M |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Trade, Taxation, Health Issues, Medicare/Medicaid
- •Medicare and Medicaid Policy
- •Drug Pricing
- •ACA-related Issues
- •Issues relating to FDA Approval
- •Intellectual Property
- •Tax issues, including tax reform, OD tax credit
- •Trade issues
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.